[Potassium canreonate and myocardial hyperexitability].
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002264:Carboxylic Acids / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007664:Ketosteroids / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D011188:Potassium / Q000097:blood; D011245:Pregnadienes / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood
D000889:Anti-Arrhythmia Agents; D002264:Carboxylic Acids; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes; D012964:Sodium; D011188:Potassium
Canrenoate de potassium et hyperexcitabilité myocardique